Digma Medical

Digma Medical Overview

Digma aims to harness the power of the duodenum to empower patients and physicians with safe, simple and effective new therapies for type 2 diabetes that enable them to live longer, healthier and happier lives. The company is developing a minimally invasive therapy, Endoscopic Glycemic Management (EGM), that aims to restore the body’s natural ability to control blood glucose levels. The treatment targets the duodenal submucosa which is central to nutrient sensing and metabolic signaling. The product consists of a console and a single-use catheter that is compatible with the working channel of standard gastrointestinal endoscopes. The EGM procedure is being developed so that it can be performed in a standard GI endoscopy suite without requiring additional imaging equipment. The goal is to provide patients with durable improvement in glycemic control with minimal side effects and without requiring additional daily medical therapy.

Cumulative Funding Raised Over Time ($)

Latest News

No news articles.

Funding

Team Members

3

Employees: 11-50

Web & Social Links

Locations

Ha'arava St 1, Giv'at Shmuel, Israel

Photos & Videos

1 item(s)

Digma Medical Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info